PL
STJ

Parkwood LLC’s St Jude Medical STJ Stock Holding History

Parkwood LLC’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-3,252
Closed -$261K – 576
2016
Q4 		$261K Buy
+3,252
New +$258K 0.04% 375
2014
Q1 		– Sell
-1,481
Closed -$92K – 530
2013
Q4 		$92K Buy
+1,481
New +$85.8K 0.02% 512

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Parkwood LLC's STJ Position: Q1 2017 in Review

Parkwood LLC sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 3,252 shares — an estimated $261K sold.

Parkwood LLC first reported a position in STJ in Q4 2013 and held it in 2 quarters. The position peaked at $261K in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Parkwood LLC reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Parkwood LLC sold 3,252 St Jude Medical shares in Q1 2017, an estimated $261K.
  • Parkwood LLC first reported a position in St Jude Medical in Q4 2013 and held it in 2 quarters.
  • Parkwood LLC's St Jude Medical position peaked at $261K in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Parkwood LLC's 13F filing for Q1 2017, filed 5 May 2017.